Overview
Investment Type
Venture Capital
Mentions in press and media 13
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Aug 6, 2012 | Respicardia Receives $6M Senior Credit Facility from Ares Capital Corporation | Respicardia, Inc., a near Minneapolis, Minnesota-based early stage company developing a medical device targeted to improve respiratory and cardiovascular health by treating central sleep apnea, has received a $6m senior secured credit facil... |
| Jan 11, 2011 | Wound healing firm Celleration raises $8 million | Promoted Clinical Care Capacity Planning Learn how to manage clinical care capacity more efficiently during uncertain times. SAP Promoted Covid-19’s terrible toll on diabetes patients. What can be done? The public health crisis has undermin... |
| Mar 25, 2010 | Anulex raises $3.8M for spinal surgery device | The first-generation iteration of the Xclose was cleared for U.S. use in general and orthopedic surgery in 2006. The device has been used in more than 7,300 procedures, according to the company. The most recent cash infusion brings Anulex’s... |
| Mar 25, 2010 | Anulex Technologies pulls in $4 million | By Brandon Glenn Fresh from the launch of its next-generation spinal tissue repair device, Anulex Technologies Inc. raised $3.8 million iun a debt and options sale to 11 investors, according to a regulatory filing. Last month, Anulex began ... |
| Feb 18, 2010 | Affinity Capital and Triathlon Medical Ventures plan new $10M early stage fund in Minnesota | Promoted Clinical Care Capacity Planning Learn how to manage clinical care capacity more efficiently during uncertain times. SAP Promoted Telemedicine’s potential to provide healthcare to the world’s most vulnerable Teladoc Health Head of R... |
| Jun 15, 2009 | Anulex Technologies raises $10.2 million in fourth funding round | Promoted Telemedicine’s potential to provide healthcare to the world’s most vulnerable Teladoc Health Head of R&D Yulun Wang highlights the impact of virtual care in underserved populations around the globe through the World Telehealth ... |
| May 10, 2007 | Pegasus Bio gets $20M for surgical-repair bioimplants | Pegasus Biologics, an Irvine, Calif., maker of flexible-but-strong tissue substitutes designed to speed muscle-tendon repair or wound healing, raised $20 million in a third round of funding. Despite the word “biologics” in its name — a term... |
| Affinity Capital and Triathlon Medical Ventures plan new $10M early stage fund in Minnesota | MINNEAPOLIS, Minnesota — Affinity Capital Management, a well-known local venture capital firm that invests heavily in medical device and health care start-ups, is collaborating with Triathlon Medical Ventures of Cincinnati to launch a $10 m... | |
| Wound healing firm Celleration raises $8 million | Eden Prairie-based Celleration has raised $8 million in Series E stock toward more sales and marketing resources for its mist therapy wound healing product. CEO Mark Wagner, who joined the company in 2009, said by phone that Celleration att... |
Show more
Reviews 0
FAQ about Affinity Capital Management
What has the press written about Affinity Capital Management?
Parsers VC has collected 13 articles mentioning Affinity Capital Management, among them “Respicardia Receives $6M Senior Credit Facility from Ares Capital Corporation” (Aug 6, 2012) and “Wound healing firm Celleration raises $8 million” (Jan 11, 2011).
Is Affinity Capital Management still active?
Yes, Affinity Capital Management is active; its latest activity on Parsers VC dates from Nov 12, 2012.